CBCE Launches Oncology-Focused CME App for the iPad®

Wednesday, May 18, 2011 General News
Email Print This Page Comment bookmark
Font : A-A+

IRVING, Texas, May 18, 2011 /PRNewswire/ -- The CBCE™ (The Center for Biomedical Continuing Education), a leading provider

of accredited, oncology-specific continuing medical education (CME), announces a new CBCE oncology-focused CME application exclusively for the iPad.

In leveraging Apple® mobile technology, the CBCE Oncology CME app allows for fully accredited

treatment updates, conference highlights and CME activities to be used by healthcare professionals in a convenient format. Content includes coverage of both solid tumors and hematologic malignancies.

"The CBCE is pleased to offer this application to the oncology community," said Shawn Whalen Shinn, senior vice president of the CBCE. The app is now available for immediate download from the Apple App Store, free of charge.

"The CBCE app is a smart, convenient CME option for busy healthcare professionals. Oncologists, hematologists and other healthcare professionals will now have access to fully accredited multimedia CME content that they may not otherwise have time to participate in," noted Shinn.  

"The CBCE app makes excellent use of the possibilities offered by the iPad platform. The app is very clean and has an intuitive user interface. It provides a comprehensive compilation of CME activities with multimedia capabilities," says Axel Grothey, professor of oncology in the Division of Medical Oncology at the Mayo Clinic in Rochester, Minn.

This continually updated application draws from select CME content found on www.thecbce.com. CME programs will be available in a variety of media formats, including podcasts, webcasts, slides and text. This application takes advantage of the best functionality this device has to offer and contains the following features:

  • Free, oncology-focused CME/CE 24/7
  • Audio, video and text formats available
  • Large iPad screen size to allow physicians and healthcare professionals even easier access to education
  • Focus on tumor-specific content for more personalized education
  • Scrolling oncology news ticker featuring award-winning HealthDay professional news, updated daily
  • Continuity between the new CBCE app for the iPad and app for the iPhone® and iPod touch®: Physicians can start a program on their iPad and finish on their iPhone or iPod touch
  • Automatic alerts each time a new program is available
  • Keyword searches to find the exact CME content needed
  • Live local, regional and national medical education activity listings with GPS capabilities

For more information on the CBCE app for the iPad, please visit www.thecbce.com/app. To go directly to the Apple App Store, please visit http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewSoftware?id=317839789&mt=8

About the CBCE

The CBCE™ (The Center for Biomedical Continuing Education) is a leading full-service provider of accredited CME and continuing education with a circular scope of capabilities. Since 1999, the CBCE has partnered with clinical experts in solid tumors and hematologic malignancies to develop and implement local, regional, national and international medical education initiatives designed to accelerate the adoption of best practices and clinical breakthroughs in oncology. The CBCE is dedicated to creating rigorous educational programs at the forefront of science, customized according to the target audience. Our unique experience in oncology and hematology has resulted in an in-depth understanding of the nuanced working lives and learning styles of the specialists, nurses and pharmacists involved in cancer care. This understanding promotes the development of all interventions.

The CBCE vision is to encourage healthcare professionals to commit to change and define distinct outcomes in their practices to improve patient care and quality of life.

SOURCE The Center for Biomedical Continuing Education


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store